A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation

GLIA

Volumn 62, Issue 9, 2014, Pages 1513-1529

  Baxi, Emily G ^a   Schott, Jason T ^a   Fairchild, Amanda N ^a   Kirby, Leslie A ^a   Karani, Rabia ^a   Uapinyoying, Prech ^a   Pardo Villamizar, Carlos ^a   Rothstein, Jeffrey R ^a   Bergles, Dwight E ^a   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GC 1; Myelination; Oligodendrocytes; Thyroid hormone

Indexed keywords

MYELIN PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SOBETIROME; THYROID HORMONE RECEPTOR BETA; ACETIC ACID DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; PHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CONTROLLED STUDY; CORPUS CALLOSUM; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IN VITRO STUDY; MOUSE; MYELINATION; NONHUMAN; OCCIPITAL CORTEX; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL; TRANSGENIC MOUSE; ADOLESCENT; AGONISTS; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CHILD; DRUG EFFECTS; EPILEPSY; GRAY MATTER; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SPRAGUE DAWLEY RAT; YOUNG ADULT;

ACETATES; ADOLESCENT; ANIMALS; BRAIN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; GRAY MATTER; HUMANS; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL STEM CELLS; NEUROGENESIS; OLIGODENDROGLIA; OPTIC NERVE; PHENOLS; RATS, SPRAGUE-DAWLEY; THYROID HORMONE RECEPTORS BETA; YOUNG ADULT;

EID: 84904277861     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22697     Document Type: Article

References (60)

1. Baas D, Bourbeau D, Carre JL, Sarlieve LL, Dussault JH, Puymirat J. 1994a. Expression of alpha and beta thyroid receptors during oligodendrocyte differentiation. Neuroreport 5:1805-1808.
2. Baas D, Bourbeau D, Sarlieve LL, Ittel ME, Dussault JH, Puymirat J. 1997. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 19:324-332.
3. Baas D, Fressinaud C, Ittel ME, Reeber A, Dalencon D, Puymirat J, Sarlieve LL. 1994b. Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3, 5, 3'-triiodo-l-thyronine. Neurosci Lett 176:47-51.
4. Baas D, Puymirat J, Sarlieve LL. 1998. Posttranscriptional regulation of oligodendroglial thyroid hormone (T3) receptor beta 1 by T3. Int J Dev Neurosci 16:461-467.
5. Badea TC, Wang Y, Nathans J. 2003. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci 23:2314-2322.
6. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108.
7. Barres BA, Schmid R, Sendnter M, Raff MC. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
8. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
9. Baxter JD, Dillmann WH, West BL, Huber R, Furlow JD, Fletterick RJ, Webb P, Apriletti JW, Scanlan TS. 2001. Selective modulation of thyroid hormone receptor action. J Steroid Biochem Mol Biol 76:31-42.
10. Bernal J. 2002. Action of thyroid hormone in brain. J Endocrinol Invest 25:268-288.
11. Bernal J. 2007. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 3:249-259.
12. Besnard F, Luo M, Miehe M, Dussault JH, Puymirat J, Sarlieve LL. 1994. Transient expression of 3, 5, 3'-triiodothyronine nuclear receptors in rat oligodendrocytes: In vivo and in vitro immunocytochemical studies. J Neurosci Res 37:313-323.
13. Billon N, Jolicoeur C, Tokumoto Y, Vennstrom B, Raff M. 2002. Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1). EMBO J 21:6452-6460.
14. Billon N, Tokumoto Y, Forrest D, Raff M. 2001. Role of thyroid hormone receptors in timing oligodendrocyte differentiation. Dev Biol 235:110-120.
15. Borngraeber S, Budny MJ, Chiellini G, Cunha-Lima ST, Togashi M, Webb P, Baxter JD, Scanlan TS, Fletterick RJ. 2003. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc Natl Acad Sci USA 100:15358-15363.
16. Bottenstein JE, Sato GH. 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517.
17. Bury F, Carre JL, Vega S, Ghandour MS, Rodriguez-Pena A, Langley K, Sarlieve LL. 2002. Coexpression of thyroid hormone receptor isoforms in mouse oligodendrocytes. J Neurosci Res 67:106-113.
18. Calza L, Fernandez M, Giuliani A, Aloe L, Giardino L. 2002. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 99:3258-3263.
19. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC, Scanlan TS. 1998. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5:299-306.
20. Darras VM. 2008. Endocrine disrupting polyhalogenated organic pollutants interfere with thyroid hormone signalling in the developing brain. Cerebellum 7:26-37.
21. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA. 2010. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597-611.
22. Dugas JC, Ibrahim A, Barres BA. 2012. The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration. Mol Cell Neurosci 50:45-57.
23. Durand B, Raff M. 2000. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22:64-71.
24. Farsetti A, Desvergne B, Hallenbeck P, Robbins J, Nikodem VM. 1992. Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. J Biol Chem 267:15784-15788.
25. Farsetti A, Mitsuhashi T, Desvergne B, Robbins J, Nikodem VM. 1991. Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J Biol Chem 266:23226-23232.
26. Foran DR, Peterson AC. 1992. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene. J Neurosci 12:4890-4897.
27. Franco PG, Silvestroff L, Soto EF, Pasquini JM. 2008. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination. Exp Neurol 212:458-467.
28. Freitas FR, Moriscot AS, Jorgetti V, Soares AG, Passarelli M, Scanlan TS, Brent GA, Bianco AC, Gouveia CH. 2003. Spared bone mass in rats treated with thyroid hormone receptor TR beta-selective compound GC-1. Am J Physiol Endocrinol Metab 285:E1135-E1141.
29. Gao FB, Apperly J, Raff M. 1998. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol 197:54-66.
30. Gloss B, Trost S, Bluhm W, Swanson E, Clark R, Winkfein R, Janzen K, Giles W, Chassande O, Samarut J, Dillmann W. 2001. Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor alpha or beta. Endocrinology 142:544-550.
31. Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD, Scanlan TS. 2004. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: Selective actions relative to 3, 5, 3'-triiodo-l-thyronine. Endocrinology 145:1656-1661.
32. Gullberg H, Rudling M, Salto C, Forrest D, Angelin B, Vennstrom B. 2002. Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol 16:1767-1777.
33. Jeannin E, Robyr D, Desvergne B. 1998. Transcriptional regulatory patterns of the myelin basic protein and malic enzyme genes by the thyroid hormone receptors alpha1 and beta1. J Biol Chem 273:24239-24248.
34. Johansson C, Vennstrom B, Thoren P. 1998. Evidence that decreased heart rate in thyroid hormone receptor-alpha1-deficient mice is an intrinsic defect. Am J Physiol 275:R640-R646.
35. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. 2010. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68:668-681.
36. Liu YW, Lo LJ, Chan WK. 2000. Temporal expression and T3 induction of thyroid hormone receptors alpha1 and beta1 during early embryonic and larval development in zebrafish, Danio rerio. Mol Cell Endocrinol 159:187-195.
37. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
38. Mansen A, Tiselius C, Sand P, Fauconnier J, Westerblad H, Rydqvist B, Vennstrom B. 2010. Thyroid hormone receptor alpha can control action potential duration in mouse ventricular myocytes through the KCNE1 ion channel subunit. Acta Physiol (Oxf) 198:133-142.
39. Manzano J, Morte B, Scanlan TS, Bernal J. 2003. Differential effects of triiodothyronine and the thyroid hormone receptor beta-specific agonist GC-1 on thyroid hormone target genes in the brain. Endocrinology 144:5480-5487.
40. Miron VE, Rajasekharan S, Jarjour AA, Zamvil SS, Kennedy TE, Antel JP. 2007. Simvastatin regulates oligodendroglial process dynamics and survival. Glia 55:130-143.
41. Miyabara EH, Aoki MS, Soares AG, Saltao RM, Vilicev CM, Passarelli M, Scanlan TS, Gouveia CH, Moriscot AS. 2005. Thyroid hormone receptor-beta-selective agonist GC-24 spares skeletal muscle type I to II fiber shift. Cell Tissue Res 321:233-241.
42. O'Shea PJ, Williams GR. 2002. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 175:553-570.
43. Othman A, Frim DM, Polak P, Vujicic S, Arnason BG, Boullerne AI. 2011. Olig1 is expressed in human oligodendrocytes during maturation and regeneration. Glia 59:914-926.
44. Rodriguez-Pena A, Ibarrola N, Iniguez MA, Munoz A, Bernal J. 1993. Neonatal hypothyroidism affects the timely expression of myelin-associated glycoprotein in the rat brain. J Clin Invest 91:812-818.
45. Rusch A, Ng L, Goodyear R, Oliver D, Lisoukov I, Vennstrom B, Richardson G, Kelley MW, Forrest D. 2001. Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors. J Neurosci 21:9792-9800.
46. Sarlieve LL, Rodriguez-Pena A, Langley K. 2004. Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage. Neurochem Res 29:903-922.
47. Scanlan TS. 2010. Sobetirome: A case history of bench-to-clinic drug discovery and development. Heart Fail Rev 15:177-182.
48. Sim FJ, Lang JK, Ali TA, Roy NS, Vates GE, Pilcher WH, Goldman SA. 2008. Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation. Glia 56:954-962.
49. Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M. 2010. Identification of a novel human thyroid hormone receptor beta isoform as a transcriptional modulator. Biochem Biophys Res Commun 396:983-988.
50. Tancevski I, Demetz E, Eller P. 2011. Sobetirome: A selective thyromimetic for the treatment of dyslipidemia. Recent Pat Cardiovasc Drug Discov 6:16-19.
51. Tancevski I, Eller P, Patsch JR, Ritsch A. 2009. The resurgence of thyromimetics as lipid-modifying agents. Curr Opin Investig Drugs 10:912-918.
52. Temple S, Raff MC. 1986. Clonal analysis of oligodendrocyte development in culture: Evidence for a developmental clock that counts cell divisions. Cell 44:773-779.
53. Tosic M, Torch S, Comte V, Dolivo M, Honegger P, Matthieu JM. 1992. Triiodothyronine has diverse and multiple stimulating effects on expression of the major myelin protein genes. J Neurochem 59:1770-1777.
54. Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH. 2000. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141:3057-3064.
55. Weiss RE, Forrest D, Pohlenz J, Cua K, Curran T, Refetoff S. 1997. Thyrotropin regulation by thyroid hormone in thyroid hormone receptor beta-deficient mice. Endocrinology 138:3624-3629.
56. Williams GR. 2000. Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Mol Cell Biol 20:8329-8342.
57. Wilson HC, Onischke C, Raine CS. 2003. Human oligodendrocyte precursor cells in vitro: Phenotypic analysis and differential response to growth factors. Glia 44:153-165.
58. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
59. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. 2007. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10:321-330.
60. Zoeller RT, Rovet J. 2004. Timing of thyroid hormone action in the developing brain: Clinical observations and experimental findings. J Neuroendocrinol 16:809-818.